Aptadir Therapeutics
RNA inhibitor-based therapeutics developer for treating intractable cancers and genetic conditions.
1
Funding Rounds
$1.6m
Money raised
Overview
RNA inhibitor-based therapeutics developer for treating intractable cancers and genetic conditions.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Ko**** | - | - | - |
| Da**** Te*** | - | - | - |
| Vi* De Fr*** | - | - | - |
| An* Di Ru**** |
|
- | - |
| Gi* Am |
|
- |
Funding series
Funding Series Analysis
The company Aptadir Therapeutics has raised a total of $1.6m in funding over 1 rounds.
Key Insights:
- Aptadir Therapeutics Pre-Seed Round, September 2024: $1.6m
Aptadir Therapeutics Pre-Seed Round, September 2024
$1.6m
Industries
Aptadir Therapeutics is active in the following industries: